Skip to content
naulon
Not checkedNot checked for notices yet.

DeepTI: A deep learning-based framework decoding tumor-immune interactions for precision immunotherapy in oncology

Jianfei Ma, Yan Jin, Yuanyuan Tang and 1 more

SLAS Discovery · 2022

doi:10.1016/j.slasd.2021.12.003 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background: Increasing evidence suggests the immunomodulatory potential of genes in oncology. But the identification of immune attributes of genes is costly and time-consuming, which leads to an urgent demand to develop a prediction model. Method: We developed a deep learning-based model to predict the immune properties of genes. This model is trained in 70% of samples and evaluated in 30% of samples. Furthermore, it uncovers 60 new immune-related genes. We analyzed the expression perturbation and prognostic value of these genes in gastric cancer. Finally, we validated these genes in immunotherapy-related datasets to check the predictive potential of immunotherapeutic sensitivity. Result: This model classifies genes as immune-promoted or immune-inhibited based on the human PPI network and it achieves an accuracy of 0.68 on the test set. It uncovers 60 new immune-related genes, most of which are validated in the published literature. These genes are found to be downregulated in gastric cancer and significantly associated with the immune microenvironment in gastric cancer. Analysis of immunotherapy shows that these genes can discriminate between responder and non-responder. Conclusion: This model can facilitate the identification of immune properties of genes, decoding tumor-immune interactions for precision immunotherapy in oncology.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.